The role of cerebral blood flow (CBF) on a maximal breath-hold (BH) in ultra-elite divers was examined. Divers (n = 7) performed one control BH, and one BH following oral administration of the non-selective cyclooxygenase inhibitor indomethacin (1.2 mg/kg). Arterial blood gases and CBF were measured prior to (baseline), and at BH termination. Compared to control, indomethacin reduced baseline CBF and cerebral delivery of oxygen (CDO 2 ) by about 26% (p < 0.01). Indomethacin reduced maximal BH time from 339 ± 51 to 319 ± 57 seconds (p = 0.04). In both conditions, the CDO 2 remained unchanged from baseline to the termination of apnea. At BH termination, arterial oxygen tension was higher following oral administration of indomethacin compared to control (4.05 ± 0.45 vs. 3.44 ± 0.32 kPa). The absolute increase in CBF from baseline to the termination of apnea was lower with indomethacin (p = 0.01). These findings indicate that the impact of CBF on maximal BH time is likely attributable to its influence on cerebral H + washout, and therefore central chemoreceptive drive to breathe, rather than to CDO 2 .
Introduction
The practice of extreme voluntary breath as arterial oxygen content (CaO 2 ) decreases during apnea [3] . To mechanistically address this CBF compensation, the next logical step was to manipulate the CBF, and observe the consequence on maximal breath holding time. Efforts to describe the impact of CBF under acute hypoxic stress are fundamental for understanding pathology or circumstances of impaired CBF in hypoxia (e.g. with surgery, respiratory disease, and ischemic stroke).
Acute hypoxia increases CBF [4] . While the mechanisms involved are complex (including the interplay between vasoactive agents, deoxyhemoglobin and PaCO 2 [5] ), it is likely that the CBF is targeted to maintain CDO 2 [6] . Indeed, in extreme breath holding (over 5 min), PaO 2 is reduced to about 4 kPa, but CDO 2 never falls below resting baseline levels [3] . The corollary effect of increased CBF is greater washout of CO 2 from brain tissue [7, 8] , and a consequent attenuation of central chemoreceptor stimulation, and ultimately the drive to breathe [9] . A reduced CBF may therefore reduce maximum BH duration not only by limiting CDO 2 , but also by augmenting brain tissue acidosis and the central drive to breathe.
The purpose of this study was to determine the impact of a reduced CBF (via the non-selective cyclooxygenase inhibitor indomethacin) on maximal BH time in ultraelite apnea divers. The CBF, CDO 2 , PaO 2 and PaCO 2 were quantified. Ultra-elite apnea divers were utilized to limit variability associated with BH motivation, and to examine the most severe levels of combined hypoxia and hypercapnia achievable in unanesthetized humans. It was hypothesized that a reduction in CBF with Indo would decrease maximal BH duration, consequent to a reduced CDO 2 , and increased cerebral acidosis; i.e., reduced CO 2 washout. 
Results
Maximal apnea time was significantly reduced with Indo (319 ± 57 s) compared to Control (339 ± 51 s), p = 0.04, d = 0.39 (Fig. 1) .
Arterial blood gases
Absolute values for PaO 2 , PaCO 2 , SaO 2 and pH during Indo and Control for baseline and end of apnea are presented in Table 1 . There were no significant differences in any blood gas variable at baseline between Indo and Control. In 
Discussion
This study demonstrates that Indo attenuates CBF resulting in a moderate reduction of maximal BH tolerance. Given that CDO 2 at baseline did not differ from CDO 2 at end-apnea in both Indo and Control trials, the reduced maximal BH following CBF attenuation is likely not related to CDO 2 , and likely more related to the decreased cerebral CO 2 washout, and therefore cerebral acidosis at the level of the central chemoreceptors leading to an augmented drive to breathe. Indeed, the tolerable level of hypoxemia (SaO 2 ) was about 9% higher during the Indo, compared to the Control apnea.
What determines the apnea breakpoint?
The mechanisms of BH breakpoint have been topic of several reviews (e.g. [2, 12, 13] Cerebral blood flow and CO2/H+ 'washout'
By administering Indo, the central drive to breathe was likely increased via reductions in the CBF response to apnea, which reduces CO 2 /H + washout from the medulla and in turn decreases pH [ [7, 8] and see Fig 7. in [9] ].
Theoretically, in a closed system independent of metabolism, flow equivalent to three times cerebral blood volume must pass through the cerebral vasculature for cerebral CO 2 to reach 95% equilibrium between arterial and tissue compartments with a steady state step increase in CO 2 [see discussion in [16] ]. Therefore, while true equilibrium is never reached in vivo, CBF will dictate the magnitude of partial equilibration (i.e., tissue-arterial gradient).
The average 24% reduction in posterior CBF We decided not to perform a second day placebo group to avoid multiple arterial catheterizations.
Indomethacin reduces cerebrovascular reactivity to CO 2 across the anterior and posterior circulation [9, 17] as well as cerebral O 2 reactivity in the posterior circulation [9] .
Although we were unable to measure blood flow in the vertebral artery, we observed an attenuated increase in absolute PCAv per unit time throughout the BH in the Control compared to the Indo condition. This finding supports the notion of reduced brainstem blood flow [9] , and therefore CO 2 /H + washout at the level of the central chemoreceptors.
Conclusion
We have previously demonstrated that a threshold 
